Ann Lab Med.  2018 Mar;38(2):179-181. 10.3343/alm.2018.38.2.179.

Abrupt Increase in Rate of Imipenem Resistance in Acinetobacter baumannii Complex Strains Isolated from General Hospitals in Korea and Correlation With Carbapenem Administration During 2002–2013

• Kim YA
• Park YS
• Youk T
• Lee H
• Lee K

• KMID: 2403367
• DOI: http://doi.org/10.3343/alm.2018.38.2.179

Abstract

No abstract available.

MeSH Terms

Acinetobacter baumannii*
Acinetobacter*
Hospitals, General*
Imipenem*
Korea*
Imipenem

Figure

• 

  Fig. 1 Correlation of national carbapenem usage with rate of imipenem resistance in Acinetobacter baumannii (IMP-R-ABA) strains isolated from general hospitals in Korea from 2002 to 2013. Correlation of imipenem usage with IMP-R-ABA (correlation coefficient r=0.93, P<0.0001); correlation of meropenem usage with IMP-R-ABA (r=0.93, P<0.0001); correlation of ertapenem usage with IMP-R-ABA (r=0.92, P=0.0002); correlation of total carbapenem usage with IMP-R-ABA (r=0.94, P<0.0001).

Reference

1. Lee Y, Kim YA, Song W, Lee H, Lee HS, Jang SJ, et al. Recent trends in antimicrobial resistance in intensive care units in Korea. Korean J Nosocomial Infect Control. 2014; 19:29–36.

2. Jasemi S, Douraghi M, Adibhesami H, Zeraati H, Rahbar M, Boroumand MA, et al. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multi-center study in Tehran, Iran over a 3-year period. Lett Appl Microbiol. 2016; 63:466–472. PMID: 27626896.

3. Levy SB. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004; 10(12 Suppl):S122–S1S9. PMID: 15577930.

4. KCDC. Korean Antimicrobial Resistance Monitoring System 2013 annual report. Accessed on June 18 2017. cdc.go.kr/CDC/cms/cmsFileDownload.jsp?fid=136&cid=21224&fieldname.

5. Lee J, Lee JS, Park S, Shin SA, Kim KW. Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017; 46:e15. DOI: 10.1093/ije/dyv319. PMID: 26822938.

6. World Health Organization Collaborating Centre for Drug Statistics and Methodology. Definitions and general considerations. last updated December 20, 2016. accessed June 18, 2017. http://www.whocc.no/ddd/definition_and_general_considera/#DDDs.

7. Gurung M, Rho JS, Lee YC, Kim HS, Moon SY, Yu BH, et al. Emergence and spread of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect Genet Evol. 2013; 19:219–222. PMID: 23886617.

8. Kim YH. Conditional probability analysis of multidrug resistance in Gram-negative bacilli isolated from tertiary medical institutions in South Korea during 1999-2009. J Microbiol. 2016; 54:50–56. PMID: 26727902.

9. Aliramezani A, Douraghi M, Hajihasani A, Mohammadzadeh M, Rahbar M. Clonal relatedness and biofilm formation of OXA-23-producing carbapenem resistant Acinetobacter baumannii isolates from hospital environment. Microb Pathog. 2016; 99:204–208. PMID: 27569533.

10. Morgenstern H. Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health. 1995; 16:61–81. PMID: 7639884.